CAS NO: | 1441000-45-8 |
包装 | 价格(元) |
100mg | 电议 |
250mg | 电议 |
500mg | 电议 |
生物活性 | Opiranserin (VVZ-149), a non-opioid and non-NSAID analgesic candidate, is a dual antagonist ofglycine transporter type 2 (GlyT2)andserotonin receptor 2A (5HT2A), withIC50s of 0.86 and 1.3 μM, respectively. Opiranserin shows antagonistic activity on rP2X3 (IC50=0.87 μM). Opiranserin is development as an injectable agent for the treatment of postoperative pain[1][2][3]. | |||
IC50& Target[2] |
| |||
Clinical Trial | ||||
分子量 | 394.51 | |||
Formula | C21H34N2O5 | |||
CAS 号 | 1441000-45-8 | |||
运输条件 | Room temperature in continental US; may vary elsewhere. | |||
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |